Barr Laboratories, a subsidiary of Barr Pharmaceuticals (BRL), announce the dismissal of litigation related to its challenge of the patent protecting Eli Lilly and Company's ZYPREXA Zydis Orally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results